Cardiovasc Drugs Ther (2017) 31:303–309 DOI 10.1007/s10557-017-6738-x ORIGINAL ARTICLE Primary Care Physician Perspectives on Barriers to Statin Treatment 1 2 3 3 Rikki M. Tanner & Monika M. Safford & Keri L. Monda & Benjamin Taylor & 4 4 1 5 Ronan O’Beirne & Melanie Morris & Lisandro D. Colantonio & Ricardo Dent & 1 6 Paul Muntner & Robert S. Rosenson Published online: 14 July 2017 Springer Science+Business Media, LLC 2017 Abstract robin fashion. Then, each PCP independently ranked their Purpose Discontinuation of statin therapy represents a major top three responses to each question. For each PCP, the challenge for effective cardiovascular disease prevention. It is most important reason was given a weight of 3 votes, and unclear how often primary care physicians (PCPs) re-initiate the second and third most important reasons were given statins and what barriers they encounter. We aimed to identify weights of 2 and 1, respectively. We categorized the indi- PCP perspectives on factors influencing statin re-initiation. vidual responses into themes and determined the relative Methods We conducted six nominal group discussions with importance of each theme using a Bpercent of available 23 PCPs from the Deep South Continuing Medical Education votes^ metric. network.
Cardiovascular Drugs and Therapy – Springer Journals
Published: Jul 14, 2017
It’s your single place to instantly
discover and read the research
that matters to you.
Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.
All for just $49/month
Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly
Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.
Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.
Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.
All the latest content is available, no embargo periods.
“Hi guys, I cannot tell you how much I love this resource. Incredible. I really believe you've hit the nail on the head with this site in regards to solving the research-purchase issue.”Daniel C.
“Whoa! It’s like Spotify but for academic articles.”@Phil_Robichaud
“I must say, @deepdyve is a fabulous solution to the independent researcher's problem of #access to #information.”@deepthiw
“My last article couldn't be possible without the platform @deepdyve that makes journal papers cheaper.”@JoseServera